Skip to main content
. Author manuscript; available in PMC: 2018 Jan 24.
Published in final edited form as: Am J Med. 2011 Mar;124(3):235–243. doi: 10.1016/j.amjmed.2010.10.016

Figure 1.

Figure 1

The prevalence of radical prostatectomy, brachytherapy, androgen deprivation therapy (ADT), external beam radiation therapy (EBRT), and conservative management by Charslon co-morbidity score in men diagnosed with localized prostate cancer, SEER-Medicare 2004–2005.

Charlson co-morbidity score was derived from Medicare claims during the year before prostate cancer diagnosis using a validated algorithm.18